Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization.
暂无分享,去创建一个
B. Fevang | L. Folkersen | U. Hedin | G. Hansson | T. Ueland | P. Aukrust | L. Gullestad | A. Yndestad | E. Biessen | A. Michelsen | T. Ranheim | B. Halvorsen | D. Russell | M. Skjelland | K. Krohg‐Sørensen | Sverre Holm | I. Daissormont | E. L. Sagen | L. Smedbakken | S. Holm
[1] Lasse Folkersen,et al. Prediction of Ischemic Events on the Basis of Transcriptomic and Genomic Profiling in Patients Undergoing Carotid Endarterectomy , 2012, Molecular medicine.
[2] C. Weber,et al. Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.
[3] J. Cyster,et al. Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. , 2010, International immunology.
[4] Carl Nathan,et al. Nonresolving Inflammation , 2010, Cell.
[5] G. Getz,et al. Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE−/− mice , 2009, The Journal of experimental medicine.
[6] F. Tacke,et al. Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.
[7] M. Meyer-Hermann,et al. Mechanisms of organogenesis of primary lymphoid follicles. , 2006, International immunology.
[8] Christian Weber,et al. Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[9] A. Chang,et al. CXC Chemokine Ligand 13 and CC Chemokine Ligand 19 Cooperatively Render Resistance to Apoptosis in B Cell Lineage Acute and Chronic Lymphocytic Leukemia CD23+CD5+ B Cells1 , 2006, The Journal of Immunology.
[10] I. Charo,et al. Targeted Disruption of the Scavenger Receptor and Chemokine CXCL16 Accelerates Atherosclerosis , 2006, Circulation.
[11] G. Hansson,et al. Inflammation and atherosclerosis. , 2006, Annual review of pathology.
[12] Lisa M. Ebert,et al. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. , 2005, Molecular immunology.
[13] M. Salmon,et al. Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5 , 2004, Arthritis research & therapy.
[14] U. Höpken,et al. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity , 2003, Immunological reviews.
[15] C. Weyand,et al. Ectopic Germinal Center Formation in Rheumatoid Synovitis , 2003, Annals of the New York Academy of Sciences.
[16] P. Debré,et al. Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice , 2003, Circulation.
[17] P. Libby,et al. Progression of Atheroma: A Struggle Between Death and Procreation , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[18] E. S. Baekkevold,et al. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue , 2002, Gut.
[19] P. Loetscher,et al. Homing chemokines in rheumatoid arthritis , 2002, Arthritis research.
[20] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[21] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[22] Jason G. Cyster,et al. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 , 1998, Nature.
[23] R. Terkeltaub,et al. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.